Degradable particles comprising high levels of rapamycin
AssigneeDsm IP Assets B.V.
InventorsMatilde PUTTI, Megan HOEN, Gueorgui MIHOV, Jérôme George Jozeph Louis LEBOUILLE
Life of this patent
Estimating the term…
Abstract
Disclosed are drug delivery devices, coatings, and microparticles that achieve sufficiently small particle sizes with high loading of Rapamycin. In an embodiment, a balloon comprises a coating on its exterior surface, the coating comprising microparticles having a Dv90 particle size of from 1 to 11 μm, as measured with static laser scattering, the microparticles comprising from 35 to 50 wt % of rapamycin, based on the total weight of the microparticles, and a random copolymer according to Formula (I).
Claims23
A balloon comprising a coating on its exterior surface, the coating comprising microparticles having a Dv90 particle size of from 1 to 11 μm, as measured with static laser scattering, the microparticles comprising from 35 to 50 wt % of rapamycin, based on the total weight of the microparticles, and a random copolymer according to Formula I:
- wherein
- m, p, q, and x represent the equivalents of the corresponding units in the random copolymer and m+p+q+x=1;
- m is from 0 to 0.75, p is from 0 to 0.75, m+p is from is from 0.5 to 0.9, q is from 0.05 to 0.25, x is from 0.01 to 0.25, and q:x is from 9:1 to 1:4;
- n is from 5 to 300;
- R1 is C2-C20 alkylene;
- R3 and R4 are hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C6-C10)aryl, —CH2SH, —(CH2)2S(CH3), —CH2OH, —CH(OH)CH3, —(CH2)4NH3+, —(CH2)3NHC(═NH2+)NH2, —CH2COOH, —CH2—CO—NH2, —CH2CH2—CO—NH2, —CH2CH2COOH, CH3—CH2—CH(CH3)—, (CH3)2CH—CH2—, H2N—(CH2)4—, Ph-CH2—, CH═C—CH2—, (CH3)2CH—, Ph-NH—,
- wherein R3 and R4 may be the same or different;
- R6 is according to Formula II or Formula III;
- R7 is (C6-C10)aryl(C1-C6)alkylene;
- and
- R8 is C3-C8 alkylene.
A method of forming microparticles comprising the steps of:
- a. forming an oil phase comprising from 1 to 2.5 wt % Rapamycin, 1.5 to 2.5 wt % of a random copolymer according to Formula I, and from 95 to 97.5 wt % of chloroform or dichloromethane,
- b. forming a continuous phase comprising water and from 0 to 1 wt % of an emulsifier, and
- c. adding the oil phase to continuous phase under high shear,
- wherein the random copolymer according to Formula I is as follows:
- wherein
- m, p, q, and x represent the equivalents of the corresponding units in the random copolymer and m+p+q+x=1;
- m is from 0 to 0.75, p is from 0 to 0.75, m+p is from is from 0.5 to 0.9, q is from 0.05 to 0.25, x is from 0.03 to 0.25, and q:x is from 9:1 to 1:4;
- n is from 5 to 300;
- R1 is C2-C20 alkylene;
- R3 and R4 are hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C6-C10)aryl, —CH2SH, —(CH2)2S(CH3), —CH2OH, —CH(OH)CH3, —(CH2)4NH3+, —(CH2)3NHC(═NH2+)NH2, —CH2COOH, —CH2—CO—NH2, —CH2CH2—CO—NH2, —CH2CH2COOH, CH3—CH2—CH(CH3)—, (CH3)2CH—CH2—, H2N—(CH2)4—, Ph-CH2—, CH═C—CH2—, (CH3)2CH—, Ph-NH—,
- wherein R3 and R4 may be the same or different;
- R6 is according to Formula II or Formula III;
- R7 is (C6-C10)aryl(C1-C6)alkylene;
- and
- R8 is C3-C8 alkylene.
A plurality of microparticles having a Dv90 particle size of from 1 to 11 μm, as measured with static laser scattering, the microparticles consisting of from 35 to 50 wt % of rapamycin, based on the total weight of the microparticles, and a random copolymer according to Formula I:
- wherein
- m, p, q, and x represent the equivalents of the corresponding units in the random copolymer and m+p+q+x=1;
- m is from 0 to 0.75, p is from 0 to 0.75, m+p is from is from 0.5 to 0.9, q is from 0.05 to 0.25, x is from 0.01 to 0.25, and q:x is from 9:1 to 1:4;
- n is from 5 to 300;
- R1 is C2-C20 alkylene;
- R3 and R4 are hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C6-C10)aryl, —CH2SH, —(CH2)2S(CH3), —CH2OH, —CH(OH)CH3, —(CH2)4NH3+, —(CH2)3NHC(═NH2+)NH2, —CH2COOH, —CH2—CO—NH2, —CH2CH2—CO—NH2, —CH2CH2COOH, CH3—CH2—CH(CH3)—, (CH3)2CH—CH2—, H2N—(CH2)4—, Ph-CH2—, CH═C—CH2—, (CH3)2CH—, Ph-NH—,
- wherein R3 and R4 may be the same or different;
- R6 is according to Formula II or Formula III;
- R7 is (C6-C10)aryl(C1-C6)alkylene;
- and
- R8 is C3-C8 alkylene.
Dependencies are inferred from the claim text.